股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 康臣葯業集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本 ...

启明创投创始主管合伙人邝子平、千里科技董事长印奇 7月31日消息，2025年世界人工智能大会（WAIC）期间，千里科技董事长印奇和启明创投创始主管合 伙人邝子平围绕《"AI+终端"进化论：大模型赋能终端进化与产业重构》展开了一场专题对话。 印奇坦言，从过去14年创业历程来看，当时"创业是先跳下悬崖，再组装飞机"这一观点现在来看是错误 的，AI领域的创业应该先要对技术、产品、商业化的基础要素进行初步设计，而没有闭环的商业模式 是无法持续推动技术进步的。 "其实在2011年刚开始创业的时候，当时是大学生创业的热潮，当时讲得最多的一句话是'创业是先跳下 悬崖，再组装飞机'这样一个概念。我今天看来这个观点是错误的，AI作为消耗资源在全球范围内极 大，是最激烈的竞争行业里，在创业的时候，至少要把创业从技术到产品、到商业化的基础要素有个大 概的设计，因为真正创业过程中，没有人知道未来怎么样。但如果整个创业模式里的基础要素缺失或者 错误，我觉得再努力可能都是往错误的方向狂奔，我自己认为，不能闭环的商业模式是无法持续推动技 术进步的。"印奇称。 印奇，出生于1988年，拥有清华大学计算机科学实验班（"姚班"）计算机科学学士学 ...

Summary of Key Points Core Viewpoint - On July 18, 22 Hong Kong-listed companies conducted share buybacks, totaling 13.19 million shares and an aggregate amount of HKD 36.71 million [1][2]. Group 1: Buyback Details - VITASOY INT'L repurchased 1.044 million shares for HKD 9.67 million, with a highest price of HKD 9.260 and a lowest price of HKD 9.250, bringing its total buyback amount for the year to HKD 137.23 million [1][2]. - China International Marine Containers (CIMC) bought back 1.263 million shares for HKD 8.69 million, with a highest price of HKD 7.020 and a lowest price of HKD 6.700, totaling HKD 56.01 million in buybacks for the year [1][2]. - China Eastern Airlines repurchased 1.75 million shares for HKD 5.04 million, with a highest price of HKD 2.940 and a lowest price of HKD 2.850, accumulating HKD 575.79 million in buybacks this year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on July 18 was from VITASOY INT'L at HKD 9.67 million, followed by CIMC at HKD 8.69 million, and China Eastern Airlines also featured prominently [1][2]. - In terms of share quantity, the largest buyback was by Ying Group with 3 million shares, followed by Sincere International and China Eastern Airlines with 2 million and 1.75 million shares respectively [1][2].

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on July 18, 2025, with VITASOY INT'L leading in terms of buyback amount and quantity [1][2]. Company Buyback Details - **VITASOY INT'L (00345)**: - Buyback quantity: 1.044 million shares - Buyback amount: 9.6671 million [2] - Year-to-date buyback quantity: 14.574 million shares, representing 1.358% of total shares [2] - **中集集团 (02039)**: - Buyback quantity: 1.263 million shares - Buyback amount: 8.6893 million [2] - Year-to-date buyback quantity: 8.6108 million shares, representing 0.280% of total shares [2] - **百胜中国 (09987)**: - Buyback quantity: 16,500 shares - Buyback amount: 6.2518 million [2] - Year-to-date buyback quantity: 2.8399 million shares, representing 0.760% of total shares [2] - **中国东方航空股份 (00670)**: - Buyback quantity: 1.750 million shares - Buyback amount: 5.0398 million [2] - Year-to-date buyback quantity: 96.208 million shares, representing 1.859% of total shares [2] - **贝壳-W (02423)**: - Buyback quantity: 634,900 shares - Buyback amount: 4 million [2] - Year-to-date buyback quantity: 1.0836 million shares, representing 0.300% of total shares [2] Additional Companies Involved - **蒙牛乳业 (02319)**: - Buyback quantity: 200,000 shares - Buyback amount: 3.393 million [2] - Year-to-date buyback quantity: 4.75 million shares, representing 0.121% of total shares [2] - **信利国际 (00732)**: - Buyback quantity: 2 million shares - Buyback amount: 2.4 million [2] - Year-to-date buyback quantity: 44.522 million shares, representing 1.408% of total shares [2] - **名创优品 (09896)**: - Buyback quantity: 57,000 shares - Buyback amount: 1.9943 million [2] - Year-to-date buyback quantity: 2.7211 million shares, representing 0.219% of total shares [2] Summary of Buyback Trends - The buyback activities indicate a trend among companies to return capital to shareholders, with varying levels of commitment reflected in the percentage of total shares repurchased [1][2].

Core Viewpoint - As of July 18, 160 stocks reached their 52-week highs, with notable performances from China New Economy Investment (00080), Aoyuan Group Equity (02905), and Zhong An Holdings Group (08462) showing high growth rates of 288.89%, 55.28%, and 50.00% respectively [1][2]. Summary by Category 52-Week High Performers - China New Economy Investment (00080) closed at 0.440, with a peak price of 0.700, achieving a growth rate of 288.89% [2]. - Aoyuan Group Equity (02905) closed at 0.218, with a peak price of 0.250, achieving a growth rate of 55.28% [2]. - Zhong An Holdings Group (08462) closed at 0.221, with a peak price of 0.228, achieving a growth rate of 50.00% [2]. - Other notable performers include Hualian International (00969) with a growth rate of 40.13% and Zhongke Bio (01237) with a growth rate of 37.25% [2]. Additional High Performers - Wanma Holdings (06928) closed at 0.550 with a growth rate of 30.43% [2]. - Lepu Biopharma-B (02157) closed at 7.940 with a growth rate of 24.54% [2]. - Other stocks with significant growth include ZhiJianYueDong (06860) at 17.14% and China Jindian Group (08281) at 17.12% [2]. 52-Week Low Performers - The document also lists stocks that reached their 52-week lows, with XI Ernan CO-U (09311) showing a decline of 16.10% [6]. - Other notable declines include XI Ernan CO (07311) at -12.62% and Haotian International Construction Investment (01341) at -5.70% [6].

Summary of Key Points Core Viewpoint - On July 16, 22 Hong Kong-listed companies conducted share buybacks, totaling 15.2022 million shares and an amount of 32.662 million HKD [1][2]. Group 1: Buyback Details - China Eastern Airlines repurchased 2.5 million shares for 7.2631 million HKD, with a highest price of 2.950 HKD and a lowest price of 2.890 HKD, accumulating a total buyback amount of 564.32 million HKD for the year [1][2]. - China International Marine Containers repurchased 947,400 shares for 6.4245 million HKD, with a highest price of 6.850 HKD and a lowest price of 6.580 HKD, accumulating a total buyback amount of 42.8144 million HKD for the year [1][2]. - China Xuyang Group repurchased 1.38 million shares for 3.4859 million HKD, with a highest price of 2.540 HKD and a lowest price of 2.500 HKD, accumulating a total buyback amount of 158.3874 million HKD for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on July 16 was from China Eastern Airlines at 7.2631 million HKD, followed by China International Marine Containers at 6.4245 million HKD [1][2]. - In terms of share quantity, the most shares repurchased on July 16 were by China Electric Power, with 4.008 million shares, followed by China Eastern Airlines with 2.5 million shares and Jieli Trading with 2 million shares [1][2].

Group 1 - The article reports on share buybacks conducted by various companies on July 16, 2025, with China Eastern Airlines having the largest buyback amount of 7.2631 million yuan for 2.5 million shares [1][2] - A total of 20 companies participated in the buyback, including notable names such as Mengniu Dairy, IGG, and Modern Dental [1] - The cumulative buyback amounts and percentages of total shares for each company are detailed, indicating varying levels of commitment to share repurchase programs [2] Group 2 - China Eastern Airlines (00670) repurchased 2.5 million shares, totaling 7.2631 million yuan, representing 1.782% of its total share capital [2] - Other companies like CIMC (02039) and China Xuyang Group (01907) also engaged in buybacks, with CIMC repurchasing 947,400 shares for 6.4245 million yuan, accounting for 0.220% of its total shares [2] - The buyback activities reflect a strategic move by these companies to enhance shareholder value and signal confidence in their financial health [1][2]

Group 1 - The article reports on stock buybacks conducted by various companies on July 15, 2025, with a total of 20 companies participating in the buyback program [1] - The company with the largest buyback amount was Wan Ka Yi Lian (01762), repurchasing 7.14 million shares for a total of 5.06 million yuan [1][2] - Other notable buybacks include Mengniu Dairy (02319) with 300,000 shares for 4.97 million yuan and China International Marine Containers (02039) with 613,100 shares for 4.03 million yuan [2] Group 2 - The cumulative buyback figures for the year show Wan Ka Yi Lian (01762) has repurchased a total of 17.37 million shares, representing 0.981% of its total share capital [2] - Other companies with significant cumulative buyback percentages include Kangchen Pharmaceutical (01681) at 5.926% and China Aluminum Can (06898) at 3.900% [2] - The buyback activity reflects a strategic move by these companies to enhance shareholder value and signal confidence in their financial health [1][2]

Group 1 - The major shareholder and chairman of Kangchen Pharmaceutical has continuously increased his stake, acquiring a total of 278,000 shares at an average price of HKD 11.34, indicating confidence in the company's future development [1] - Since June 16, Kangchen Pharmaceutical has repurchased shares 15 times, totaling 4.795 million shares and an expenditure of HKD 53.8248 million, reflecting the company's commitment to returning value to shareholders [3] - The company's core product, Uremic Granules, is the only "strongly recommended" medication listed in the clinical application guidelines for chronic kidney disease, showcasing its leading position in the kidney disease sector [6] Group 2 - Kangchen Pharmaceutical is actively expanding its product portfolio beyond kidney disease, venturing into six additional fields, establishing a "1+6" product structure to enhance its market presence [6][7] - The company has a clear strategic focus on innovation, with a pipeline that includes both traditional Chinese medicine and innovative drugs, prioritizing the kidney and imaging sectors [7] - Despite recent stock price increases, Kangchen Pharmaceutical's price-to-earnings (PE) ratio remains around 10 times, suggesting that its innovative value is yet to be fully realized [8]

7月4日，"格隆汇·中期策略峰会·2025"于深圳盛大开幕。其中，在"格隆汇·金格奖"ESG卓越公司评选中，康臣药业（01681.HK）荣获"ESG社会责任卓越企 业"奖项。 "ESG社会责任卓越企业"奖项旨在表彰在社会公益、员工权益保障、社区共建等方面展现卓越担当的企业，重点关注其在乡村振兴、普惠包容性发展等国家 战略中的实践成果，树立商业向善的行业榜样。 同日，康臣药业管理层亮相峰会路演环节。秉承着"承古拓新，良药济民"的企业使命，康臣药业在医药行业中已拥有较高的品牌知名度及患者的认可度，努 力"打造肾科旗舰，成为多专科领先的一流医药企业"。 稳增长与高分红并举，持续回馈股东价值 从财报数据来看，2013年上市至今，康臣药业的业绩一直处于"稳健增长"姿态。 截止2024年，康臣药业的营收年复合增长率达16.1%，净利润年复合增长率达17.6%，其中近三年ROE均保持在20%以上，远高于同期同业表现情况。 在业绩稳健增长的背景之下，康臣药业也持续通过高比例分红派息积极回馈广大股东。 根据WIND数据统计显示，过往十年（2014-2024年），康臣药业年平均派息比率超30%。其中，2024年公司派息比率更是进 ...